Found 0 matching trials
Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial
PHASE2The strategy to support virological suppression on second-line antiretrovir...
Location
Khayelitsha Site B/Ubuntu Community Health Clinic
Efficacy and Safety of DTG/3TC in Treatment-naïve HIV-1 Infected Patients
N/ANon-interventional, retrospective, single arm study of individuals who have...
Status
Enrolling By Invitation
Location
Chungnam National University Hospital, 282 Munwha-ro
Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)
PHASE4The aim is to investigate whether Lamivudine 100mg daily is effective in th...
Location
Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital
Study of Combivir for Patients With Primary Biliary Cirrhosis
PHASE2This is a proof of principal study to determine whether combination anti-vi...
Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral Suppression
PHASE1We hypothesize that a simple bridging ARV regimen that tends to select for ...
Location
University of Maryland Baltimore, Institute of Human Virology
DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old
PHASE2This study aims to find out whether treating children and young people livi...
Status
Active Not Recruiting
Location
King Edward VIII Hospital
Lamivudine for Solid Tumors
PHASE1Single arm, set dose clinical trial of Lamivudine for Relapsed Refractory S...
Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai
ARVs to Prevent Breastmilk HIV:Viral and Immune Responses
PHASE2Identifying new approaches for preventing breastmilk transmission of HIV-1 ...
Location
University of Nairobi
Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)
PHASE3The primary purpose of this study is to assess the rate of early discontinu...
Location
Multiple Locations
Early Infant HIV Treatment in Botswana
PHASE2The overall objective of this study is to determine whether very early anti...
Status
Active Not Recruiting
Location
Botswana Harvard HIV/AIDS Institute Partnership